Target intelligence / Profile preview

T cell receptor alpha variable 4 (TRAV4)

Target
TRAV4
Molecular classification
Receptor, Immunoglobulin superfamily, Non-catalytic tyrosine-phosphorylated receptor (NTR)
01

Overview

T cell receptor alpha variable 4 (TRAV4) is a **variable region gene segment** of the alpha chain of the T cell receptor (TCR) complex, predominantly expressed on the surface of T lymphocytes as part of the alpha-beta TCR heterodimer[1][2][3]. The TCR enables T cells to recognize and bind to specific antigen fragments presented by major histocompatibility complex (MHC) molecules on antigen-presenting cells, initiating essential signaling cascades for immune activation[1][2]. TRAV4, like other TCR variable segments, contributes to the diversity of antigen recognition via V(D)J recombination, allowing the immune system to respond to a vast array of pathogens[2][3]. Members of the TCR family are central to **adaptive immunity**, are classified as **immunoglobulin superfamily receptors**, and play direct roles in anti-infective and antitumor immune function. Dysfunction or dysregulation of TCRs, including those with TRAV4, can result in immune deficiencies, autoimmune diseases, or aberrant immune activation[1][3].

Other names
TCRAV20S1TCRAV4S1TRAV4T-cell receptor alpha variable 4
02

Biological functions

Antigen recognitionImmune responseSignal transductionT cell activation and differentiation
03

Disease associations

Cancer (role as an immune receptor in tumor surveillance)Infection (key to pathogen recognition)Inflammation (mediator of immune responses)Other (can be involved in autoimmunity through recognition of self-antigens)
04

Safety considerations

Potential for autoimmunity if recognition or tolerance failsNon-specific activation could cause cytokine release syndromeTargeting TCRs can affect broad T-cell populations, raising immunosuppression risks

Beyond the preview

Go deeper on T cell receptor alpha variable 4 (TRAV4).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on T cell receptor alpha variable 4 (TRAV4).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call